毫末智行涵盖用于私家车的自动驾驶系统以及企业采购的物流车自动驾驶方案，面向乘用车与低速末 端物流市场形成双产品战略。毫末智行以数据智能为核心，从低速无人物流车、乘用车自动驾驶产品、低速物流智能 硬件三大产品布局自动驾驶业务，进而组成公司的“风车战略”。

数字营销：受益于内容视频化、渠道一体化、传播去中心化，短视频营销、KOL营销、私域营销成为目前最为流行的营销方式。分为短视频营销、KOL营销、私域营销。营销内容：视频化与直播正当时，精品与快消内容分化。营销媒介：各有所长，按需投放。

Gene therapy is “a novel approach to treat, cure, or ultimately prevent disease by changing the expression of a person’s genes” (AMA, 2016). Gene therapies repair, deactivate, or replace dysfunctional genes that cause diseases, with the aim of establishing normal functioning of the body. Around 4,000 diseases have been linked to gene disorders, which affect millions of people across the globe.

Genomic data analysis is a computational process that helps researchers and clinicians to analyze and interpret data generated by modern genomics technologies, such as NGS and PCR. The genomic data analysis steps typically include data collection, quality check, data cleaning, processing, modeling, visualization, and reporting, through which the data can be further translated to potential insights. As sequencing technologies are producing millions of high-quality reads per run, the adoption of robust genomic data analysis software solutions has increased significantly over the past few years.

Gene therapy cell culture media is a substance composed of various nutrients that are essential for the growth, maintenance, development, proliferation, and storage of cells. A culture media contains constituents such as glucose, attachment & growth factors, and other important elements that supplement cellular growth. In this report, the global gene therapy cell culture media market is analyzed using the revenue generated by sales of culture media involved in life science and biotechnology research. However, the report does not consider revenue generated by sales of reagents, sera, disposables, consumables, and instruments involved in life sciences and healthcare research.

The first method of sequencing was introduced around half a century ago, and since then, sequencing technologies have continued to evolve, especially after the appearance of the first sequencers from next-generation sequencing (NGS) technology, which appeared in 2005. These technologies are characterized by their high throughput, which gives the opportunity to produce millions of reads with inexpensive sequencing. NGS and nanopore technologies are now the starting point for several areas of research based on the study and analysis of biological sequences.